http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2542421-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f83739934fdc2a7659b796aa25a36413 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 |
| filingDate | 2014-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b988ec2379244b609d67a3e2335a84d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3fb245b2e5f6176a91995a1c3c3696a |
| publicationDate | 2015-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2542421-C1 |
| titleOfInvention | Method of treating atopic dermatitis in children with secondary immunodeficiency syndrome |
| abstract | FIELD: medicine. n SUBSTANCE: common therapy is conducted in the patient according to standard regimen. Additionally, from the first therapeutic day, Ananferon for kids and Virefon, suppositories are prescribed. Anaferon for kids is administered subglosally without regard to food in a dose of 1 tablet once a day for 2 months. Viferon, rectal suppositories are used 2 times a day every 12 hours for 30 days according to the schedule: for the first 10 days, 1 suppository of 1,000,000 international units, for the following 10 days, 1 suppository of 500,000 international units and then 1 suppository of 150,000 international units. n EFFECT: using the given method enables normalising the immune status values, prolonging the remission of clinical manifestations of atopic dermatitis in the children with secondary immunodeficiency syndrome. n 2 ex |
| priorityDate | 2014-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.